Примери за използване на Recommended for use in children and adolescents на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Not recommended for use in children and adolescents.
Paediatric population{Invented Name} is not recommended for use in children and adolescents.
Arava is not recommended for use in children and adolescents below 18 years of age.
No data are available, Raplixa is therefore not recommended for use in children and adolescents.
Jalra is not recommended for use in children and adolescents(< 18 years).
Teveten is not recommended for use in children and adolescents due to lack of data on safety and efficacy.
Karvezide is not recommended for use in children and adolescents because the safety and efficacy have not been established.
Therefore Velphoro is not recommended for use in children and adolescents.
CoAprovel is not recommended for use in children and adolescents due to a lack of data on safety and efficacy.
It is not recommended for use in children and adolescents below 18 years of age, due to a lack of data on safety and efficacy.
Rivastigmine is not recommended for use in children and adolescents.
INTANZA is not recommended for use in children and adolescents below 18 years.
Therefore Arzerra is not recommended for use in children and adolescents.
Fulphila is not recommended for use in children and adolescents due to insufficient data on safety and effectiveness.
DepoCyte is not recommended for use in children and adolescents until further data become available.
Vidaza is not recommended for use in children and adolescents below the age of 18.
ChondroCelect is therefore not recommended for use in children and adolescents below 18 years.
PREZISTA is not recommended for use in children and adolescents because there are no data on safety, efficacy and pharmacokinetics.
This medicine is not recommended for use in children and adolescents under 18 years.
Leflunomide Teva is not recommended for use in children and adolescents below 18 years of age.
Aerivio Spiromax is not recommended for use in children and adolescents aged less than 18 years.
This medicinal product is not recommended for use in children and adolescents under the age of 18 years.